40.50
+0.89(+2.25%)
Currency In USD
Address
980 Great West Road
Brentford, TW8 9GS
United Kingdom of Great Britain and Northern Ireland
Phone
44 20 8047 5000
Website
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
68629
First IPO Date
March 28, 1980
| Name | Title | Pay | Year Born |
| Ms. Emma Natasha Walmsley | Chief Executive Officer & Director | 5.98M | 1969 |
| Ms. Sally Jackson | Senior Vice President of Global Communications & Chief Executive Officer Office | 0 | N/A |
| Dr. Jesse L. Goodman M.D., M.P.H. | Scientific & Medical Expert | 228,000 | 1951 |
| Ms. Julie Belita Brown A.C.A. | Chief Financial Officer & Executive Director | 5.54M | 1962 |
| Mr. Tony Wood | Chief Scientific Officer and Head of R&D | 0 | N/A |
| Mr. James Ford | Senior Vice President & Group General Counsel of Legal & Compliance | 0 | N/A |
| Mr. Philip C. Thomson | President of Global Affairs | 0 | N/A |
| Ms. Shobie Ramakrishnan | Chief Digital & Technology Officer | 0 | 1971 |
| Ms. Diana Conrad | Chief People Officer | 0 | N/A |
| Mr. David Simon Redfern BSc (Hons), CA | President of Corporate Development | 0 | 1966 |
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.